Category: IPOs

Key developments: This week’s IPO action was dominated by biotech. City Therapeutics surged 28% on debut, reaching a $1.19 billion valuation, and Iambic Therapeutics jumped to $23.87 after pricing at $16 per share. Both deals underscore robust demand for…

Continue reading Biotech leads a quiet week while AI‑heavy Anthropic eyes a potential blockbuster debut

Key developments: City Therapeutics kicked off the week with a strong debut, pricing at $18.00 per share and jumping 28% to $23.00, valuing the company at roughly $1.19 billion. The market’s focus then shifted to Anthropic, which remains the…

Continue reading Biotech Leads Quiet Week as Anthropic Awaits IPO Queue

Key developments – City Therapeutics surged 28% on its $18‑midpoint pricing, finishing its debut at $23 and expanding the offering to $200 million, signaling robust demand for late‑stage biotech listings. Iambic Therapeutics followed, pricing at $16 and quickly climbing…

Continue reading Biotech leads a strong debut week while AI‑centric Anthropic stalls and Jio Platforms gears up for India’s biggest IPO

Key developments: Jio Platforms, the telecom and digital services arm of Reliance Industries, is set to open its IPO next week, offering 270 million new shares at ₹1,065‑₹1,119 each. The filing could raise roughly Rs 30,000 crore, making it the largest…

Continue reading Jio Platforms to launch India’s biggest ever IPO, targeting a Rs 30,000‑crore raise

Jio Platforms Ltd. is slated to open its initial public offering on 21 October, offering 270 million new shares at a price band of ₹1,065‑₹1,119 each. The issue, valued at roughly ₹30,200 crore (about ₹10.3 lakh crore market cap), is expected to raise…

Continue reading Jio Platforms launches record‑size ₹30,200 crore IPO, set to become India’s biggest listing